Viewing Study NCT03288012


Ignite Creation Date: 2025-12-26 @ 10:46 PM
Ignite Modification Date: 2025-12-26 @ 10:46 PM
Study NCT ID: NCT03288012
Status: UNKNOWN
Last Update Posted: 2019-07-19
First Post: 2017-09-13
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Sickle Cell Disease: Targeting Alloantibody Formation Reduction; Risk Factors, and Genetics
Sponsor: Sanquin Research & Blood Bank Divisions
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2017-09-20
Start Date Type: ACTUAL
Primary Completion Date: 2021-06-01
Primary Completion Date Type: ESTIMATED
Completion Date: 2021-12-31
Completion Date Type: ESTIMATED
First Submit Date: 2017-09-13
First Submit QC Date: None
Study First Post Date: 2017-09-19
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2019-07-17
Last Update Post Date: 2019-07-19
Last Update Post Date Type: ACTUAL